display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
es-BC - TNBC - NA - all population
anti-PD-(L)1
atezolizumab based treatment
atezolizumab plus carboplatin plus nab-paclitaxel NeoTrip Michel Angelo
atezolizumab plus carboplatin plus paclitaxel NCI 10013 NCI 10013
atezolizumab plus nab-paclitaxel IMpassion-031 ... IMpassion-031 ...
atezolizumab plus paclitaxel ALEXANDRA/IMpassion-030
durvalumab based treatment
durvalumab alone GeparNuevo
pembrolizumab based treatment
pembrolizumab plus SoC KEYNOTE-522

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons